141 related articles for article (PubMed ID: 34706298)
1. Risk Stratifying Indeterminate Thyroid Nodules With Machine Learning.
Luong G; Idarraga AJ; Hsiao V; Schneider DF
J Surg Res; 2022 Feb; 270():214-220. PubMed ID: 34706298
[TBL] [Abstract][Full Text] [Related]
2. A 10-Gene Classifier for Indeterminate Thyroid Nodules: Development and Multicenter Accuracy Study.
González HE; Martínez JR; Vargas-Salas S; Solar A; Veliz L; Cruz F; Arias T; Loyola S; Horvath E; Tala H; Traipe E; Meneses M; Marín L; Wohllk N; Diaz RE; Véliz J; Pineda P; Arroyo P; Mena N; Bracamonte M; Miranda G; Bruce E; Urra S
Thyroid; 2017 Aug; 27(8):1058-1067. PubMed ID: 28521616
[TBL] [Abstract][Full Text] [Related]
3. False Negative Rates in Benign Thyroid Nodule Diagnosis: Machine Learning for Detecting Malignancy.
Idarraga AJ; Luong G; Hsiao V; Schneider DF
J Surg Res; 2021 Dec; 268():562-569. PubMed ID: 34464894
[TBL] [Abstract][Full Text] [Related]
4. Machine Learning-Assisted Diagnostic System for Indeterminate Thyroid Nodules.
Chen L; Chen M; Li Q; Kumar V; Duan Y; Wu KA; Pierce TT; Samir AE
Ultrasound Med Biol; 2022 Aug; 48(8):1547-1554. PubMed ID: 35660106
[TBL] [Abstract][Full Text] [Related]
5. The first Canadian experience with the Afirma® gene expression classifier test.
Kay-Rivest E; Tibbo J; Bouhabel S; Tamilia M; Leboeuf R; Forest VI; Hier MP; Savoury L; Payne RJ
J Otolaryngol Head Neck Surg; 2017 Apr; 46(1):25. PubMed ID: 28372589
[TBL] [Abstract][Full Text] [Related]
6. Ultrasonographic features associated with malignancy in cytologically indeterminate thyroid nodules.
Batawil N; Alkordy T
Eur J Surg Oncol; 2014 Feb; 40(2):182-6. PubMed ID: 24373298
[TBL] [Abstract][Full Text] [Related]
7. Targeted Next Generation Sequencing with ThyroSeq v2.1 for Indeterminate Thyroid Nodules in Clinical Practice.
Witt RL
Del Med J; 2016 Dec; 88(12):366-372. PubMed ID: 29461717
[TBL] [Abstract][Full Text] [Related]
8. Application of machine learning methods to guide patient management by predicting the risk of malignancy of Bethesda III-V thyroid nodules.
D'Andréa G; Gal J; Mandine L; Dassonville O; Vandersteen C; Guevara N; Castillo L; Poissonnet G; Culié D; Elaldi R; Sarini J; Decotte A; Renaud C; Vergez S; Schiappa R; Chamorey E; Château Y; Bozec A
Eur J Endocrinol; 2023 Mar; 188(3):. PubMed ID: 36799885
[TBL] [Abstract][Full Text] [Related]
9. Development of a clinical decision model for thyroid nodules.
Stojadinovic A; Peoples GE; Libutti SK; Henry LR; Eberhardt J; Howard RS; Gur D; Elster EA; Nissan A
BMC Surg; 2009 Aug; 9():12. PubMed ID: 19664278
[TBL] [Abstract][Full Text] [Related]
10. Application of a machine learning algorithm to predict malignancy in thyroid cytopathology.
Elliott Range DD; Dov D; Kovalsky SZ; Henao R; Carin L; Cohen J
Cancer Cytopathol; 2020 Apr; 128(4):287-295. PubMed ID: 32012493
[TBL] [Abstract][Full Text] [Related]
11. Assessing Bias and Limitations of Clinical Validation Studies of Molecular Diagnostic Tests for Indeterminate Thyroid Nodules: Systematic Review and Meta-Analysis.
DiGennaro C; Vahdatzad V; Jalali MS; Toumi A; Watson T; Gazelle GS; Mercaldo N; Lubitz CC
Thyroid; 2022 Oct; 32(10):1144-1157. PubMed ID: 35999710
[No Abstract] [Full Text] [Related]
12. Risk assessment of cytologically indeterminate thyroid nodules with integrated molecular testing and repeat biopsy: a surgical decision-oriented tool.
Guan X; Yu T; Zhang Z; Chen L; Yan A; Li Y; Li J; Wang D; Sun J; Wang F; Miao G
World J Surg Oncol; 2023 Feb; 21(1):34. PubMed ID: 36737779
[TBL] [Abstract][Full Text] [Related]
13. Performance of Afirma genomic sequencing classifier vs gene expression classifier in Bethesda category III thyroid nodules: An institutional experience.
Zhang L; Smola B; Lew M; Pang J; Cantley R; Pantanowitz L; Heider A; Jing X
Diagn Cytopathol; 2021 Aug; 49(8):921-927. PubMed ID: 34021740
[TBL] [Abstract][Full Text] [Related]
14. Fine-needle aspiration cytology of thyroid nodules--how well are we doing?
Cheung YS; Poon CM; Mak SM; Suen MW; Leong HT
Hong Kong Med J; 2007 Feb; 13(1):12-5. PubMed ID: 17277386
[TBL] [Abstract][Full Text] [Related]
15. The diagnostic accuracy of ultrasound-guided fine-needle aspiration biopsy and the sonographic differences between benign and malignant thyroid nodules 3 cm or larger.
Yoon JH; Kwak JY; Moon HJ; Kim MJ; Kim EK
Thyroid; 2011 Sep; 21(9):993-1000. PubMed ID: 21834673
[TBL] [Abstract][Full Text] [Related]
16. (99m)Tc-Methoxy-Isobutyl-Isonitrile Scintigraphy Is a Useful Tool for Assessing the Risk of Malignancy in Thyroid Nodules with Indeterminate Fine-Needle Cytology.
Campennì A; Giovanella L; Siracusa M; Alibrandi A; Pignata SA; Giovinazzo S; Trimarchi F; Ruggeri RM; Baldari S
Thyroid; 2016 Aug; 26(8):1101-9. PubMed ID: 27266385
[TBL] [Abstract][Full Text] [Related]
17. Preoperative detection of malignancy in fine-needle aspiration cytology (FNAC) smears with indeterminate cytology (Bethesda III, IV) by a combined molecular classifier.
Titov S; Demenkov PS; Lukyanov SA; Sergiyko SV; Katanyan GA; Veryaskina YA; Ivanov MK
J Clin Pathol; 2020 Nov; 73(11):722-727. PubMed ID: 32213552
[TBL] [Abstract][Full Text] [Related]
18. How to approach thyroid nodules with indeterminate cytology.
Yoon JH; Kwak JY; Kim EK; Moon HJ; Kim MJ; Kim JY; Koo HR; Kim MH
Ann Surg Oncol; 2010 Aug; 17(8):2147-55. PubMed ID: 20217250
[TBL] [Abstract][Full Text] [Related]
19. Machine Learning by Ultrasonography for Genetic Risk Stratification of Thyroid Nodules.
Daniels K; Gummadi S; Zhu Z; Wang S; Patel J; Swendseid B; Lyshchik A; Curry J; Cottrill E; Eisenbrey J
JAMA Otolaryngol Head Neck Surg; 2020 Jan; 146(1):36-41. PubMed ID: 31647509
[TBL] [Abstract][Full Text] [Related]
20. American Thyroid Association ultrasound system for the initial assessment of thyroid nodules: Use in stratifying the risk of malignancy of indeterminate lesions.
Trimboli P; Deandrea M; Mormile A; Ceriani L; Garino F; Limone PP; Giovanella L
Head Neck; 2018 Apr; 40(4):722-727. PubMed ID: 29247582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
